SPRING Trial: Liver Stiffness Measurements Improved in CM-101-Treated Patients
Chemomab Therapeutics Announces Positive Phase 2 Trial Results: CM-101 Achieves Primary and Secondary Endpoints Demonstrating Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects in Patients with Primary Sclerosing Cholangitis
25 juil. 2024 07h00 HE | Chemomab Therapeutics
Chemomab reported positive topline results from Ph 2 trial assessing CM-101 in PSC. Achieved safety endpoint and improved wide range of secondary endpoints
Logo 1-1.png
Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
18 juin 2024 07h00 HE | Chemomab Therapeutics
New publication confirms the role of CCL24 in primary sclerosing cholangitis and the potential of CM-101 to impact PSC disease progression and severity.
Great Plains Communi
Great Plains Communications Awarded $3.54 Million in Nebraska Reverse Auction
10 avr. 2024 14h00 HE | Great Plains Communications
Blair, Nebraska, April 10, 2024 (GLOBE NEWSWIRE) -- Great Plains Communications (GPC), the Midwestern digital infrastructure provider with a growing, privately owned 18,000+ mile fiber network...
Logo 1-1.png
Chemomab to Host Virtual Key Opinion Leader Webinar on Primary Sclerosing Cholangitis on April 10, 2024
02 avr. 2024 07h00 HE | Chemomab Therapeutics
Chemomab's KOL primary sclerosing cholangitis virtual event on April 10 at 10:00 AM ET will include physician & patient PSC experts & a live Q&A session.
Picture 1.jpg
PSC Consulting bolsters leadership team with appointment of European head
05 mars 2024 07h06 HE | PSC Consulting
NEWCASTLE UPON TYNE, United Kingdom, March 05, 2024 (GLOBE NEWSWIRE) -- PSC Consulting is pleased to announce the appointment of James Drummond as Managing Director of its European operations. The...
MicrosoftTeams-image (5).png
Invea Therapeutics Research to be Showcased at the Prestigious 2023 DDW Meeting
26 avr. 2023 08h10 HE | Invea Therapeutics
GUILFORD, Conn., April 26, 2023 (GLOBE NEWSWIRE) -- Invea Therapeutics (Invea), a biotechnology company developing an artificial intelligence (AI) and machine learning (ML) powered pipeline of...
meridian_newLogo-1.png
North Dakota Supreme Court Upholds Public Service Commission Decision to Dismiss Complaint on Davis Refinery Siting
16 sept. 2020 09h00 HE | Meridian Energy Group
BELFIELD, N.D., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Meridian Energy Group, Inc., the leading innovator in the petroleum refining industry, announced today that the North Dakota Supreme Court ruled in...
meridian_newLogo-1.png
North Dakota Public Service Commission Dismisses Complaint Against Meridian Energy Group, Inc.
10 oct. 2018 12h57 HE | Meridian Energy Group
BELFIELD, N.D., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Meridian Energy Group, Inc., the leading developer of innovative and environmentally-compliant oil refining facilities, announced today that a...
ERHC Energy Announces Start of EEZ PSC Negotiations, Addition to Technical Team
16 nov. 2011 16h00 HE | ERHC Energy Inc.
HOUSTON, TX--(Marketwire - Nov 16, 2011) - ERHC Energy Inc. (OTCBB: ERHE), a publicly traded American company with oil and gas assets in Sub-Saharan Africa, today announced the commencement of...
Republic of Chad Issues Presidential Decree of Approval of ERHC Energy Inc. Production Sharing Contract
23 août 2011 07h29 HE | ERHC Energy Inc.
HOUSTON, TX--(Marketwire - Aug 23, 2011) - ERHC Energy Inc. (OTCBB: ERHE), a publicly traded American company with oil and gas assets in West and Sub-Saharan Africa, today announced that the...